Vitamin D deficiency in undifferentiated connective tissue disease
Open Access
- 18 October 2008
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 10 (5) , R123
- https://doi.org/10.1186/ar2533
Abstract
Introduction: Both experimental and clinical data provide evidence that vitamin D is one of those important environmental factors that can increase the prevalence of certain autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, insulin-dependent diabetes mellitus, and inflammatory bowel disease. The aim of the present study was to investigate the prevalence of vitamin D insufficiency in patients with undifferentiated connective tissue disease (UCTD). Methods: Plasma 25(OH)D3 levels in 161 UCTD patients were measured in both summer and winter periods. Autoantibody profiles (antinuclear antibody, anti-U1-ribonucleoprotein, anti-SSA, anti-SSB, anti-Jo1, anti-Scl70, anti-double-stranded DNA, anti-centromere, anti-cardiolipin, rheumatoid factor, and anti-cyclic citrullinated peptide) and clinical symptoms of the patients were assessed. Results: Plasma levels of 25(OH)D3 in UCTD patients were significantly lower compared with controls in both summer and winter periods (UCTD summer: 33 ± 13.4 ng/mL versus control: 39.9 ± 11.7 ng/mL, P = 0.01; UCTD winter: 27.8 ± 12.48 ng/mL versus control: 37.8 ± 12.3 ng/mL, P = 0.0001). The presence of dermatological symptoms (photosensitivity, erythema, and chronic discoid rash) and pleuritis was associated with low levels of vitamin D. During the average follow-up period of 2.3 years, 35 out of 161 patients (21.7%) with UCTD further developed into well-established connective tissue disease (CTD). Patients who progressed into CTDs had lower vitamin D levels than those who remained in the UCTD stage (vitamin D levels: CTD: 14.7 ± 6.45 ng/mL versus UCTD: 33.0 ± 13.4 ng/mL, P = 0.0001). Conclusions: In patients with UCTD, a seasonal variance in levels of 25(OH)D3 was identified and showed that these levels were significantly lower than in controls during the corresponding seasons. Our results suggest that vitamin D deficiency in UCTD patients may play a role in the subsequent progression into well-defined CTDs.Keywords
This publication has 51 references indexed in Scilit:
- Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease PrevalenceExperimental Biology and Medicine, 2004
- Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune systemThe American Journal of Clinical Nutrition, 2004
- Selective Immunointervention in Autoimmune Diseases: Lessons from Multiple SclerosisJournal of Chemotherapy, 2001
- Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.2000
- 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitroExperimental Hematology, 2000
- Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D AnalogsBiochemical and Biophysical Research Communications, 2000
- 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell ActivationThe Journal of Immunology, 2000
- Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?Proceedings of the Society for Experimental Biology and Medicine, 2000
- The effects of 1α,25-dihydroxyvitamin D3 on matrix metalloproteinase and prostaglandin E2 production by cells of the rheumatoid lesionArthritis Research & Therapy, 1999
- The diagnosis of osteoporosisJournal of Bone and Mineral Research, 1994